<DOC>
	<DOCNO>NCT01693861</DOCNO>
	<brief_summary>Observational , non randomize study aim measure effect chemotherapy urinary concentration physiological modify nucleoside 30 patient metastatic colorectal cancer .</brief_summary>
	<brief_title>`` Cancersensor '' Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Histologicallyconfirmed metastatic colorectal cancer ; 0 3 prior chemotherapy line ; Signed informed consent ; Good understanding protocol followup ; Estimated life expectancy exceed 3 month ; At least one measurable metastatic lesion ( RECIST criterion ) ; Performance Status ( WHO ) 0 2 ; Good haematological , hepatic renal function . More 2 surgical resection metastasis colorectal cancer ; Poor performance status ( &gt; 2 ) ; Poor haematological , hepatic renal function ; Uncontrolled chronic disease ; Serious unhealed wound , ulcer fracture within previous month ; Clinical laboratory find suggest possible abnormality nucleoside urinary excretion ; Pregnancy breastfeed previous month ; Transmeridian trip 4 time zone within prior 2 week ; Person legal restriction participate clinical research , accord current law France .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Colorectal</keyword>
	<keyword>Cancer</keyword>
	<keyword>Metastatic</keyword>
	<keyword>Chronotherapy</keyword>
	<keyword>Urine</keyword>
	<keyword>Nucleosides</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Treated chemotherapy</keyword>
</DOC>